01 Jun 2023

Ex-manufacturer price

Ex-manufacturer price

01 Jun 2023

Ex-manufacturer price

Ex-manufacturer price

01 Jun 2023

Ex-manufacturer price

Ex-manufacturer price

26 May 2023

Health Technology Assessment Policy and Methods Review Consultation and Updates from the Health Technology Assessment Policy and Methods Review Reference Committee

Health Technology Assessment Policy and Methods Review Consultation and Updates from the Health Technology Assessment Policy and Methods Review Reference Committee

26 May 2023

Health Technology Assessment Policy and Methods Review Consultation and Updates from the Health Technology Assessment Policy and Methods Review Reference Committee

Health Technology Assessment Policy and Methods Review Consultation and Updates from the Health Technology Assessment Policy and Methods Review Reference Committee

26 May 2023

Health Technology Assessment Policy and Methods Review Consultation and Updates from the Health Technology Assessment Policy and Methods Review Reference Committee

Health Technology Assessment Policy and Methods Review Consultation and Updates from the Health Technology Assessment Policy and Methods Review Reference Committee

24 May 2023

PBAC Public Summary Documents

The Public Summary Document of the Pharmaceutical Benefits Advisory Committee’s (PBAC) consideration of the interim report of the Post-market Review of Opioid Dependence Treatment Program medicines which was considered out-of-session between March 2023 and July 2023 by the PBAC is now available.

24 May 2023

PBAC Public Summary Documents

The Public Summary Document of the Pharmaceutical Benefits Advisory Committee’s (PBAC) consideration of the interim report of the Post-market Review of Opioid Dependence Treatment Program medicines which was considered out-of-session between March 2023 and July 2023 by the PBAC is now available.

24 May 2023

PBAC Public Summary Documents

The Public Summary Document of the Pharmaceutical Benefits Advisory Committee’s (PBAC) consideration of the interim report of the Post-market Review of Opioid Dependence Treatment Program medicines which was considered out-of-session between March 2023 and July 2023 by the PBAC is now available.

12 May 2023

Outcome in relation to fluticasone propionate – PBAC May 2023 Intracycle meeting

Outcome in relation to fluticasone propionate – PBAC May 2023 Intracycle meeting